Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Sun Pharma Q4 Net Profit Zooms Over Two-Fold To Rs 894.15 Cr

Shares of Sun Pharmaceutical Industries closed at Rs 699.75 per scrip on BSE, down 0.55 per cent from its previous close.

Photo Credit :

1583139205_8SUG5q_2020_03_02T084648Z_1_LYNXMPEG210QJ_RTROPTP_4_SUN_PHARM_RESULTS.JPG

Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit to Rs 894.15 crore for the quarter ended March 31, 2021.

The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.

Consolidated revenue from operations stood at Rs 8,522.98 crore for the quarter under consideration. It was Rs 8,184.94 crore in the same period a year ago, it added.

Shares of Sun Pharmaceutical Industries closed at Rs 699.75 per scrip on BSE, down 0.55 per cent from its previous close.

(PTI)


Tags assigned to this article:
sun pharmaceuticals shares revenue drug major